SCHEMBL8544385

SCHEMBL8544385

COc1ccc2[nH]cc(CCN(C)C)c2c1Br

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.71
HTR6 P50406 5/20 0.67
HTR2A P28223 10/20 0.52
HTR2C P28335 7/20 0.52
HTR2B P41595 6/20 0.52
HTR1D P28221 3/20 0.52
HTR1B P28222 2/20 0.52
HTR1E P28566 2/20 0.52
HTR7 P34969 2/20 0.52
HTR5A P47898 2/20 0.52
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
HTR1F P30939 1/20 0.52
HTR3A P46098 1/20 0.52
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
HTR4 Q13639 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25145335 0.84 HTR1A (0.73) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL23791403 0.84 HTR1A (0.73) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL34433458 0.84 HTR1A (0.73) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL8543221 0.84 HTR1A (0.55) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL30916159 0.83 HTR1A (1.00) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL8543450 0.83 HTR1A (0.71) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL27041049 0.83 HTR1A (0.71) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL25747526 0.83 HTR1A (1.00) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL19235737 0.80 HTR6 (1.00) HTR1AHTR6HTR2AHTR2CHTR2B
SCHEMBL29993252 0.80 HTR6 (1.00) HTR1AHTR6HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP claimed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US claimed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP claimed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO claimed
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed